10-52170031-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006258.4(PRKG1):​c.1076+8068T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.444 in 152,102 control chromosomes in the GnomAD database, including 18,096 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 18096 hom., cov: 32)

Consequence

PRKG1
NM_006258.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.115

Publications

7 publications found
Variant links:
Genes affected
PRKG1 (HGNC:9414): (protein kinase cGMP-dependent 1) Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]
PRKG1-AS1 (HGNC:45029): (PRKG1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.598 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006258.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKG1
NM_006258.4
MANE Select
c.1076+8068T>C
intron
N/ANP_006249.1Q13976-2
PRKG1
NM_001098512.3
c.1031+8068T>C
intron
N/ANP_001091982.1Q13976-1
PRKG1
NM_001374781.1
c.-134+8068T>C
intron
N/ANP_001361710.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKG1
ENST00000373980.11
TSL:1 MANE Select
c.1076+8068T>C
intron
N/AENSP00000363092.5Q13976-2
PRKG1
ENST00000401604.8
TSL:5
c.1031+8068T>C
intron
N/AENSP00000384200.4Q13976-1
PRKG1
ENST00000672084.1
c.227+8068T>C
intron
N/AENSP00000499822.1A0A5F9ZGW0

Frequencies

GnomAD3 genomes
AF:
0.444
AC:
67517
AN:
151984
Hom.:
18085
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.155
Gnomad AMI
AF:
0.535
Gnomad AMR
AF:
0.607
Gnomad ASJ
AF:
0.460
Gnomad EAS
AF:
0.208
Gnomad SAS
AF:
0.382
Gnomad FIN
AF:
0.535
Gnomad MID
AF:
0.453
Gnomad NFE
AF:
0.590
Gnomad OTH
AF:
0.463
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.444
AC:
67538
AN:
152102
Hom.:
18096
Cov.:
32
AF XY:
0.440
AC XY:
32699
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.154
AC:
6407
AN:
41526
American (AMR)
AF:
0.608
AC:
9292
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.460
AC:
1595
AN:
3470
East Asian (EAS)
AF:
0.208
AC:
1074
AN:
5166
South Asian (SAS)
AF:
0.384
AC:
1844
AN:
4808
European-Finnish (FIN)
AF:
0.535
AC:
5651
AN:
10564
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.590
AC:
40079
AN:
67970
Other (OTH)
AF:
0.463
AC:
976
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1605
3209
4814
6418
8023
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.531
Hom.:
74543
Bravo
AF:
0.438
Asia WGS
AF:
0.279
AC:
970
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.2
DANN
Benign
0.42
PhyloP100
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11001056; hg19: chr10-53929791; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.